As one of the most powerful independent risk factors for ischemic stroke and the most clinically relevant arrhythmia, atrial fibrillation (AF) poses a serious clinical and public health threat as the ...

Efforts are under way at many managed care organizations (MCOs) around the United States to implement, expand, and justify the cost of anticoagulation clinics or develop anticoagulation improvement ...

BOSTON — Patients who have had a stroke are thought to be at a higher risk for another one, but oral anticoagulation with edoxaban led to no discernible reduction in the risk for a second stroke, and ...

January 26, 2004 — It is clear that warfarin therapy in patients with atrial fibrillation (AF) resulting in an international normalized ratio (INR) >= 2.0 reduces the risk of stroke. However, what is ...

Patients with atrial fibrillation who received oral anticoagulation therapy after a stroke had reduced risk for recurrent thromboembolic events vs. those who received antiplatelet therapy or no ...

Please provide your email address to receive an email when new articles are posted on . Data show early anticoagulation after acute stroke in people with atrial fibrillation is safe when indicated.

Patients with A-fib who have an ischemic stroke fare much better in subsequent years if they’re taking oral anticoagulation as opposed to antiplatelets alone or nothing at all, results from a new ...

When atrial fibrillation (AF) is detected after a cerebrovascular event, it should be treated with oral anticoagulation: that’s the general consensus of stroke experts speaking in a session on ...

"Atrial fibrillation (AF) is the most common heart rhythm disorder and affects 1.5-2% of people in the developed world," said Dr Denham. "AF increases the risk of stroke by five-fold. In addition, ...

To the Editor: Hylek and colleagues (Sept. 11 issue) 1 report that in patients with nonvalvular atrial fibrillation who were admitted with stroke, an international normalized ratio (INR) of less than ...

Data from randomized, controlled trials indicate that oral anticoagulation medication reduces the risk of stroke in patients with atrial fibrillation (AF); however, whether this treatment has any ...